Was not involved in insider trading: Sun Pharma on Ranbaxy deal
Sun Pharmaceutical Industries' Founder and Managing Director Dilip Shanghvi has said the drugmaker was not involved in any insider trading norm violation in the Ranbaxy deal. "There was a minor technical issue relating to trading window closure norms," Shanghvi said. "The case was settled with SEBI without admission of guilt and the matter was closed," he added.